ArticleFrontiers in immunology2012

Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.

Kamal D Puri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.